TMates review

Almost every provider here claiming one price at every dose declines to say which doses. TMates says. Its plan selector carries a "Same Price All Doses" badge and, directly beneath the four plan lengths, a dosage row naming every strength the price covers, from a quarter of a milligram up to the top of the range. That candour is worth crediting, and it is also what makes the structure legible: a patient deliberately holding the lowest dose is buying roughly a tenth of the drug for the identical monthly figure. The badge reads as reassurance and functions, for this site's reader, as a cost. Two other things to hold. The cheapest figure it advertises is a twelve-month commitment charged in one payment, and the month-to-month rate is more than half again as much — so the number that catches the eye is not the number most people pay. And injectable and oral are priced identically, which is admirably route-neutral but comes with no milligram figure on the oral side, so the equivalence between the two is asserted rather than shown.

Vs median

$80/mo above the $169 median across the 242 of 373 programs we track that publish a plain monthly rate

Market

$59–$1300/mo is the full published spread in our ranking

Structure

Same price at every dose

Consult

Included in the price

Dietitian

Not included

Labs

Not required

Pricing

Flat at every dose

Price last updated

August 2026

TMates does not publicly identify the pharmacy that fills its prescriptions. No bloodwork is required before you start. A clinician review is included in the price.

TMates sells compounded semaglutide and tirzepatide as a doctor-supervised weight-loss program, in either injectable or oral form at the same price, with medication and ongoing support included. Its plan selector is unusually explicit: it carries a "Same Price All Doses" badge and, directly beneath the four plan lengths, a dosage row listing every strength the price covers — 0.25 mg through 2.4 mg. Most providers making the same claim never publish the range it applies to.

THIS IS THE STRUCTURE THIS SITE EXISTS TO FLAG, and TMates publishes enough to prove it: a patient deliberately holding 0.25 mg/week pays exactly what a patient at 2.4 mg pays — nine to ten times the drug for the same money. The badge reads as a feature and is a cost to anyone intending to stay low

• The cheapest advertised figure is a twelve-month commitment charged as $1,900 upfront; the real month-to-month rate is $249, which is 58% higher
• No compounding pharmacy is named on the product page
• No milligram figure is attached to the oral form, so the equivalence between routes is asserted rather than shown
• Compounded GLP-1s are not FDA-approved, and intentional microdosing is off-label and unproven

TMates is one of 373 low-dose GLP-1 programs we track, and 242 of them publish a monthly rate you can read before signing up. The ranking lists every published price on one screen, ordered with the companies that pay us first — a mechanism we state there, on the page it applies to.

Intentional GLP-1 microdosing is off-label and unproven — no randomized trial has established that a sub-label dose does anything, and any dose belongs with a clinician who knows your history. If you are going to have that conversation, have it with real numbers.

• What the evidence actually shows
• What microdosing GLP-1 costs
• Low dose vs full dose
• What a flat price costs at a low dose
• The true annual cost of a plan